GoHealth, Inc. (GOCO)
USD 12.31
(-2.38%)
USD 12.31
(-2.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 109.14 Million | 60.9 Million | -299 Million | -114.21 Million | -3000.00 | 5.44 Million |
| Net Income | -63.25 Million | -376.38 Million | -534.19 Million | -97.2 Million | -41.06 Million | 28.11 Million |
| Depreciation & Amortization | 105.74 Million | 107 Million | 107.5 Million | 98.55 Million | 32.98 Million | 6.16 Million |
| Deferred income taxes | -7.94 Million | - | 398.48 Million | - | - | - |
| Stock-based compensation | 19.54 Million | 27.14 Million | 27.29 Million | 216.22 Million | - | - |
| Change in working capital | 116.11 Million | 270.16 Million | -306.41 Million | -352.23 Million | -151.16 Million | -29.62 Million |
| Other non-cash items | -61.07 Million | 32.98 Million | 8.31 Million | 20.43 Million | 504.79 Million | 791 Thousand |
| Investing Cash Flow | -13.73 Million | -13.51 Million | -19.8 Million | -14.52 Million | -815.6 Million | -6.17 Million |
| Investments in PPE | -13.73 Million | -13.51 Million | -19.8 Million | -14.52 Million | -8.01 Million | -6.17 Million |
| Acquisitions | - | - | - | - | -807.59 Million | - |
| Investment purchases | - | - | - | -508.32 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 508.32 Million | - | - |
| Financing Cash Flow | -21.1 Million | -115.05 Million | 259.08 Million | 260.66 Million | 827.43 Million | 63 Thousand |
| Debt repayment | -15.33 Million | -160.37 Million | -299.28 Million | -4.17 Million | -286.16 Million | -82.41 Million |
| Dividends payments | -3.56 Million | - | - | -400 Thousand | - | - |
| Common Stock Repurchased | -2.29 Million | -345 Thousand | - | -100 Million | 541.26 Million | - |
| Common Stock Issuance | 91 Thousand | -1.64 Million | - | 862.4 Million | 541.26 Million | - |
| Other Financing Activities | -2.29 Million | 47.3 Million | 558.37 Million | -497.17 Million | -541.26 Million | 82.47 Million |
| Accounts receivables | 125.09 Million | 243.84 Million | -455.7 Million | -429.11 Million | -282.62 Million | -64.7 Million |
| Accounts payables | 2.55 Million | -28.21 Million | 147.96 Million | 102.24 Million | 3.05 Million | 34 Million |
| Inventory | - | - | 1.52 Million | -10.88 Million | 11.61 Million | 957 Thousand |
| Other working capital | -11.53 Million | 54.53 Million | -200 Thousand | -14.48 Million | 128.4 Million | 126 Thousand |
| Cash at beginning of period | 16.46 Million | 84.36 Million | 144.23 Million | 12.27 Million | 505 Thousand | 1.17 Million |
| Cash at end of period | 90.8 Million | 16.46 Million | 84.36 Million | 144.23 Million | 12.27 Million | 505 Thousand |
| Capital Expenditure | -13.73 Million | -13.51 Million | -19.8 Million | -14.52 Million | -8.01 Million | -6.17 Million |
| Effect of forex changes on cash | 42 Thousand | -238 Thousand | -155 Thousand | 35 Thousand | -49 Thousand | -3000.00 |
| Net cash flow / Change in cash | 74.34 Million | -67.89 Million | -59.87 Million | 131.95 Million | 11.77 Million | -667 Thousand |
| Free Cash Flow | 95.4 Million | 47.39 Million | -318.8 Million | -128.74 Million | -8.01 Million | -727 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -25.99 Million | -9.21 Million | -63.25 Million | -1.22 Million | -56.2 Million | -70.22 Million |
| Depreciation & Amortization | 26.29 Million | 26.24 Million | 105.74 Million | 26.84 Million | 26.26 Million | 26.36 Million |
| Deferred income taxes | -40 Thousand | - | -7.94 Million | -49.14 Million | -108 Thousand | -73 Thousand |
| Stock-based compensation | 1.89 Million | 1.78 Million | 19.54 Million | 4.25 Million | 2.17 Million | 8.68 Million |
| Change in working capital | -9.38 Million | 3.64 Million | 116.11 Million | 31.02 Million | 32.96 Million | 41.53 Million |
| Other non-cash items | -10.77 Million | -3.4 Million | -61.07 Million | 59.55 Million | 1.41 Million | 4.57 Million |
| Investing Cash Flow | -2.7 Million | -4.55 Million | -13.73 Million | -5.64 Million | -3.42 Million | -2.43 Million |
| Investments in PPE | -2.7 Million | -4.55 Million | -13.73 Million | -5.64 Million | -3.42 Million | -2.43 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -35.39 Million | -942 Thousand | -21.1 Million | -1.08 Million | -2.19 Million | -15.42 Million |
| Debt repayment | -50 Million | - | -15.33 Million | -1.00 | -66 Thousand | -14.01 Million |
| Dividends payments | - | - | -3.56 Million | -891 Thousand | -892 Thousand | -891 Thousand |
| Common Stock Repurchased | -393 Thousand | -942 Thousand | -2.29 Million | 2.07 Million | -1.37 Million | -592 Thousand |
| Common Stock Issuance | - | - | 91 Thousand | 21 Thousand | 132 Thousand | 65 Thousand |
| Other Financing Activities | 15 Million | -942 Thousand | -2.29 Million | -2.29 Million | 5000.00 | - |
| Accounts receivables | 23.85 Million | 59.66 Million | 125.09 Million | -3.51 Million | 39.82 Million | 15.36 Million |
| Accounts payables | 3.04 Million | -11.93 Million | 2.55 Million | 12.31 Million | -3.21 Million | -7.42 Million |
| Inventory | - | - | - | -12.8 Million | -18.75 Million | 31.55 Million |
| Other working capital | -36.28 Million | -44.08 Million | -11.53 Million | 22.22 Million | 15.09 Million | 2.04 Million |
| Cash at beginning of period | 97.81 Million | 90.8 Million | 16.46 Million | 26.38 Million | 25.36 Million | 32.32 Million |
| Cash at end of period | 14.12 Million | 97.81 Million | 90.8 Million | 90.8 Million | 26.38 Million | 25.36 Million |
| Capital Expenditure | -2.7 Million | -4.55 Million | -13.73 Million | -5.64 Million | -3.42 Million | -2.43 Million |
| Effect of forex changes on cash | -47 Thousand | -5000.00 | 42 Thousand | -147 Thousand | 143 Thousand | 41 Thousand |
| Net cash flow / Change in cash | -83.69 Million | 7 Million | 74.34 Million | 64.42 Million | 1.02 Million | -6.96 Million |
| Free Cash Flow | -48.25 Million | 7.95 Million | 95.4 Million | 65.65 Million | 3.07 Million | 8.42 Million |
CMPR
DCOMP
AKTIA
NEWGEN
9996
ASCCF